BullFrog AI Holdings BFRG Peer Comparison

NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 0.00 Mn 6.20 222.38 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn 0.00 Mn 6.15 184.12 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 0.00 Mn 10.99 130.51 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 0.00 Mn 5.48 77.10 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 0.00 Mn 12.23 58.75 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn 0.00 Mn 26.07 52.94 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 0.00 Mn 7.41 32.28 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 0.00 Mn 3.25 31.34 Bn
9 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn 0.00 Mn 24.23 26.41 Bn
10 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn 0.00 Mn 8.48 12.58 Bn
11 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn 0.00 Mn 2,310.98 25.93 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 0.00 Mn 13.73 15.82 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn 0.00 Mn 12.28 14.93 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 0.00 Mn 20.50 13.91 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
16 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 0.00 Mn 3.78 12.00 Bn
17 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 0.00 Mn 7.55 12.34 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn 0.00 Mn 18.20 10.58 Bn
19 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 0.00 Mn 14.45 11.63 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn 0.00 Mn — 9.06 Bn
22 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn 0.00 Mn 11.01 7.57 Bn
23 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 0.00 Mn 33.42 9.42 Bn
24 ABVX Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.02 Bn 0.00 Mn — 9.02 Bn
25 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn 0.00 Mn — 8.86 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 0.00 Mn 10.72 7.89 Bn
27 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn 0.00 Mn 51.33 8.15 Bn
28 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn 0.00 Mn — 8.10 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn 0.00 Mn — 7.84 Bn
30 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn 0.00 Mn 29.47 6.74 Bn
31 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn 0.00 Mn 5,007.81 6.97 Bn
32 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn 0.00 Mn — 6.73 Bn
33 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn 0.00 Mn 1,058.74 6.59 Bn
34 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn 0.00 Mn 10.57 6.10 Bn
35 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn 0.00 Mn — 5.96 Bn
36 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn 0.00 Mn 1,163.52 5.66 Bn
37 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
38 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 0.00 Mn — 5.78 Bn
39 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 0.00 Mn 5.72 3.55 Bn
40 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 0.00 Mn 19.58 4.33 Bn
41 GRFS Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 5.31 Bn 0.00 Mn 0.32 6.86 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn 0.00 Mn — 5.06 Bn
43 RADX Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.92 Bn 0.00 Mn 20,296.96 4.92 Bn
44 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn 0.00 Mn — 4.68 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
46 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn 0.00 Mn 402.01 4.16 Bn
47 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn 0.00 Mn — 4.07 Bn
48 TLX Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.04 Bn — — 3.75 Bn
49 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn 0.00 Mn — 4.02 Bn
50 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn 0.00 Mn 16.41 3.01 Bn
51 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn 0.00 Mn — 3.80 Bn
52 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn 0.00 Mn 70.47 2.78 Bn
53 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn 0.00 Mn 32.18 3.06 Bn
54 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn 0.00 Mn 987.61 3.56 Bn
55 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn 0.00 Mn 52.94 3.50 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 0.00 Mn 19,714.47 3.11 Bn
57 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn 0.00 Mn — 3.04 Bn
58 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn 0.00 Mn 593.06 2.51 Bn
59 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 0.00 Mn 6.47 2.76 Bn
60 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn 0.00 Mn — 2.96 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn 0.00 Mn 6.55 2.24 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn 0.00 Mn — 2.80 Bn
63 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn 0.00 Mn 553.22 2.73 Bn
64 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn 0.00 Mn 73.73 2.27 Bn
65 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn 0.00 Mn 36.49 2.60 Bn
66 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn 0.00 Mn — 2.59 Bn
67 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn 0.00 Mn 4.75 2.19 Bn
68 HCM HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 0.00 Mn 3.41 2.47 Bn
69 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn 0.00 Mn 44.92 1.77 Bn
70 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn 0.00 Mn — 2.38 Bn
71 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn 0.00 Mn — 2.10 Bn
72 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn 0.00 Mn 44.88 2.34 Bn
73 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn 0.00 Mn — 1.93 Bn
74 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn 0.00 Mn — 2.22 Bn
75 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn 0.00 Mn 109.75 2.19 Bn
76 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 4.23 2.03 Bn
77 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.00 Mn 0.34 0.66 Bn
78 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.00 Mn 11.42 2.05 Bn
79 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 0.00 Mn 56.15 1.81 Bn
80 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 0.00 Mn 2,082.32 2.08 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn 0.00 Mn 18.84 1.60 Bn
82 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 20.06 1.97 Bn
83 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn 0.00 Mn 35.35 1.39 Bn
84 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn 0.00 Mn 6.35 1.93 Bn
85 LKFT Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.00 Mn 1.63 1.88 Bn
86 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn 67.43 1.57 Bn
87 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn 4.32 0.98 Bn
88 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn — 1.32 Bn
89 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn 0.00 Mn 7.27 1.29 Bn
90 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn 0.00 Mn — 1.80 Bn
91 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn 0.00 Mn 1,370.98 1.78 Bn
92 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn 0.00 Mn — 1.39 Bn
93 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn 0.00 Mn 1,008.79 1.73 Bn
94 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn 0.00 Mn — 1.71 Bn
95 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 4.07 0.97 Bn
96 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 16.97 1.68 Bn
97 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn 0.00 Mn 20.12 1.38 Bn
98 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn 0.00 Mn 8.28 1.36 Bn
99 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
100 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn 0.00 Mn — 1.53 Bn
101 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 0.00 Mn 969.66 1.31 Bn
102 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 0.00 Mn 2.10 1.22 Bn
103 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn 0.00 Mn — 1.50 Bn
104 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn 0.00 Mn 72.74 1.45 Bn
105 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn 0.00 Mn — 1.42 Bn
106 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn 165.97 0.88 Bn
107 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn 35.55 1.37 Bn
108 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
109 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn 0.00 Mn — 1.33 Bn
110 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn 0.00 Mn — 0.74 Bn
111 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn — 1.26 Bn
112 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn — 1.26 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn 3.20 1.15 Bn
114 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn 0.00 Mn — 1.25 Bn
115 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn 0.00 Mn 51.51 1.24 Bn
116 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn 0.00 Mn — 1.00 Bn
117 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 0.00 Mn — 1.18 Bn
118 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 0.00 Mn 41.06 0.55 Bn
119 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn 0.00 Mn — 1.10 Bn
120 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn 0.00 Mn — 1.06 Bn
121 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 0.00 Mn 5.60 0.93 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 4.14 0.71 Bn
123 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn 0.00 Mn — 0.95 Bn
124 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn 0.00 Mn 2.09 0.66 Bn
125 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn 0.00 Mn 14.37 0.57 Bn
126 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn 0.00 Mn 3.28 0.81 Bn
127 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 0.00 Mn 8.50 0.50 Bn
128 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 881.20 0.88 Bn
129 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn 0.00 Mn 104.97 0.86 Bn
130 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn 0.00 Mn — 0.85 Bn
131 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn — 0.84 Bn
132 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn 0.00 Mn 44.17 0.48 Bn
133 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn — 0.79 Bn
134 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn 2.37 0.63 Bn
135 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 0.00 Mn — 0.71 Bn
136 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 0.00 Mn 9.71 0.41 Bn
137 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.49 Bn
138 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1.81 0.62 Bn
139 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 1,120.86 0.62 Bn
140 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 0.00 Mn — 0.67 Bn
141 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -0.36 Mn — 0.64 Bn
142 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 0.00 Mn 16.37 0.58 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 0.00 Mn — 0.63 Bn
144 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn 1.94 0.05 Bn
145 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn 551.86 Mn 3.59 0.46 Bn
146 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 0.00 Mn — 0.59 Bn
147 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn — 0.58 Bn
148 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn 557.79 0.41 Bn
149 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 0.00 Mn — 0.56 Bn
150 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn 0.00 Mn 78.36 0.28 Bn
151 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn 0.00 Mn 9.32 0.22 Bn
152 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn — 0.50 Bn
153 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.57 0.42 Bn
154 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.11 0.39 Bn
155 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
156 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.45 Bn
157 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
158 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn 13.19 0.21 Bn
159 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 15.31 0.26 Bn
160 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 44.52 0.24 Bn
161 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn — 0.44 Bn
162 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 42.40 0.44 Bn
163 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 19.43 0.16 Bn
164 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn — 0.43 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.28 0.22 Bn
166 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
167 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn 0.00 Mn 139.55 0.21 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn 0.00 Mn — 0.36 Bn
170 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 0.00 Mn 2.65 0.34 Bn
171 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.34 Bn
172 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.33 Bn
173 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 3.70 0.17 Bn
174 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 104.23 0.33 Bn
175 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn 0.00 Mn — 0.31 Bn
176 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn 0.00 Mn — 0.31 Bn
177 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.90 0.30 Bn
178 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.19 Bn
179 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 13.14 0.29 Bn
180 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 7.86 0.22 Bn
181 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 1.67 0.17 Bn
182 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn — 0.28 Bn
183 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 59.24 0.28 Bn
184 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
185 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 19.81 0.10 Bn
186 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 23.24 0.27 Bn
187 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.15 Bn
188 YDES YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 287.04 0.25 Bn
189 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
190 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 17.81 0.21 Bn
191 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
192 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 3.31 0.16 Bn
193 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 4.34 0.08 Bn
194 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
195 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
196 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn 54.32 0.23 Bn
197 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
198 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 6.84 -0.03 Bn
199 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 4.31 0.11 Bn
200 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 10.15 0.08 Bn
201 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.19 Bn
202 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
203 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.66 0.17 Bn
204 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.21 Bn
205 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 32.66 0.21 Bn
206 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.21 Bn
207 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
208 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn 60.09 0.19 Bn
209 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn — 0.34 Bn
210 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn — 0.19 Bn
211 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 75.57 0.06 Bn
212 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 30.80 0.18 Bn
213 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 2.72 0.04 Bn
214 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 2.28 -0.05 Bn
215 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 14.38 0.14 Bn
216 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 33.39 0.17 Bn
217 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 2,035.87 -0.02 Bn
218 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn — 0.16 Bn
219 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 43.96 0.12 Bn
220 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
221 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn — 0.14 Bn
222 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — -0.03 Bn
223 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
224 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn 6.38 0.13 Bn
225 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
226 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
227 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn 1,363.19 0.14 Bn
228 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
229 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 136.38 0.14 Bn
230 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.12 Bn
231 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.01 Bn
232 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.12 Bn
233 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn 39.24 0.12 Bn
234 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.06 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn 13.92 0.07 Bn
236 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
237 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.10 Bn
238 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.09 Bn
239 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.09 Bn
240 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
241 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
242 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
243 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 60.89 0.09 Bn
244 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
245 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 1.32 -0.06 Bn
246 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 139.00 0.09 Bn
247 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
248 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
249 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
250 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
251 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
252 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.07 Bn
253 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
254 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
255 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 126.99 0.07 Bn
256 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 1.50 0.02 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
258 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 17.32 0.03 Bn
259 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 0.43 0.02 Bn
260 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn — 0.06 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn — 0.06 Bn
262 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 1,632.72 0.06 Bn
263 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 29.85 0.06 Bn
264 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.03 Bn
265 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 2.74 -0.06 Bn
266 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 5.09 0.05 Bn
267 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
268 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 3.86 0.05 Bn
269 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 294.15 -0.01 Bn
270 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 2.24 0.05 Bn
271 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
272 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 342.82 0.02 Bn
273 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
274 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
275 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 4.79 0.04 Bn
276 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.03 Bn
277 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 79.85 0.04 Bn
278 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
279 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 0.38 0.03 Bn
280 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 4.58 0.06 Bn
281 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.94 0.02 Bn
282 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.04 Bn
283 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
284 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
285 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.92 0.03 Bn
286 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
287 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 93.50 0.03 Bn
288 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 37.53 0.03 Bn
289 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
290 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
291 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 869.19 0.02 Bn
292 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.03 Bn
293 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
294 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
295 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 261.63 0.03 Bn
296 CNSY Cerenome, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.80 0.01 Bn
297 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 2.67 0.01 Bn
298 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
299 CMMB Chemomab Therapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
300 KTTA Pasithea Therapeutics Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn